BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 11039666)

  • 1. Residual erythroid progenitors in W/W mice respond to erythropoietin in the absence of steel factor signals.
    Pharr PN; Hofbauer A; Worthington RE; Longmore GD
    Int J Hematol; 2000 Aug; 72(2):178-85. PubMed ID: 11039666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of c-Kit and erythropoietin receptor in erythropoiesis.
    Munugalavadla V; Kapur R
    Crit Rev Oncol Hematol; 2005 Apr; 54(1):63-75. PubMed ID: 15780908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
    Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ
    Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the erythropoietin and stem-cell-factor receptors.
    Wu H; Klingmüller U; Besmer P; Lodish HF
    Nature; 1995 Sep; 377(6546):242-6. PubMed ID: 7545788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. W/Wv marrow stromal cells engraft and enhance early erythropoietic progenitors in unconditioned Sl/Sld murine recipients.
    Bubnic SJ; Wang XH; Clark BR; Keating A
    Bone Marrow Transplant; 2002 Dec; 30(12):867-72. PubMed ID: 12476278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
    Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sensitivity of in vitro erythropoietic progenitor cells to different erythropoietin reagents during development and the role of cell death in culture.
    Zimmermann F; Rich IN
    Exp Hematol; 1996 Feb; 24(2):330-9. PubMed ID: 8641362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence suggesting a stimulatory role for interleukin-10 in erythropoiesis in vitro.
    Wang CQ; Udupa KB; Lipschitz DA
    J Cell Physiol; 1996 Feb; 166(2):305-10. PubMed ID: 8591990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of erythroid toxicity by lentinan and erythropoietin in mice treated with chemotherapeutic agents.
    Takatsuki F; Miyasaka Y; Kikuchi T; Suzuki M; Hamuro J
    Exp Hematol; 1996 Feb; 24(3):416-22. PubMed ID: 8599970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel way to induce erythroid progenitor self renewal: cooperation of c-Kit with the erythropoietin receptor.
    Wessely O; Bauer A; Quang CT; Deiner EM; von Lindern M; Mellitzer G; Steinlein P; Ghysdael J; Beug H
    Biol Chem; 1999 Feb; 380(2):187-202. PubMed ID: 10195426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukemic transformation of normal murine erythroid progenitors: v- and c-ErbB act through signaling pathways activated by the EpoR and c-Kit in stress erythropoiesis.
    von Lindern M; Deiner EM; Dolznig H; Parren-Van Amelsvoort M; Hayman MJ; Mullner EW; Beug H
    Oncogene; 2001 Jun; 20(28):3651-64. PubMed ID: 11439328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PI3K/Akt-dependent Epo-induced signalling and target genes in human early erythroid progenitor cells.
    Sivertsen EA; Hystad ME; Gutzkow KB; Døsen G; Smeland EB; Blomhoff HK; Myklebust JH
    Br J Haematol; 2006 Oct; 135(1):117-28. PubMed ID: 16965383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sl/Sld hematopoietic progenitors are deficient in situ.
    Barker JE
    Exp Hematol; 1994 Feb; 22(2):174-7. PubMed ID: 7507859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo erythroid recovery following paclitaxel injury: correlation between GATA-1, c-MYB, NF-E2, Epo receptor expressions, and apoptosis.
    Romero-Benitez MM; Aguirre MV; Juaristi JA; Alvarez MA; Trifaró JM; Brandan NC
    Toxicol Appl Pharmacol; 2004 Feb; 194(3):230-8. PubMed ID: 14761679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo suppression of erythropoiesis by tumor necrosis factor-alpha (TNF-alpha): reversal with exogenous erythropoietin (EPO).
    Johnson CS; Cook CA; Furmanski P
    Exp Hematol; 1990 Feb; 18(2):109-13. PubMed ID: 2303102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparate regulation of human fetal erythropoiesis by the microenvironments of the liver and bone marrow.
    Muench MO; Namikawa R
    Blood Cells Mol Dis; 2001; 27(2):377-90. PubMed ID: 11259159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional interaction of erythropoietin and stem cell factor receptors is essential for erythroid colony formation.
    Wu H; Klingmüller U; Acurio A; Hsiao JG; Lodish HF
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1806-10. PubMed ID: 9050860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perturbation of autocrine/paracrine loops of burst-forming units of erythroid-derived cells in rHuEPO-hyporesponsive hemodialysis patients.
    Nakao K; Wada J; Ota K; Ichikawa H; Akagi S; Okamoto A; Hida K; Nagake Y; Makino H
    Am J Kidney Dis; 2003 Mar; 41(3):624-36. PubMed ID: 12612986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mechanism of cooperation between c-Kit and erythropoietin receptor. Stem cell factor induces the expression of Stat5 and erythropoietin receptor, resulting in efficient proliferation and survival by erythropoietin.
    Kapur R; Zhang L
    J Biol Chem; 2001 Jan; 276(2):1099-106. PubMed ID: 11042182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of the in vitro effects of testosterone and erythropoietin on Cfu-E and Bfu-E proliferation by pretreatment of the donor rats with cyproterone and flutamide.
    Malgor LA; Valsecia M; Vergés E; De Markowsky EE
    Acta Physiol Pharmacol Ther Latinoam; 1998; 48(2):99-105. PubMed ID: 9695882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.